HCWB HCW Biologics Inc

P/E --
Forward P/E --
Price/Sales 0.819
Beta 2.302
Div Yield --
Market Cap --

Company Analysis

Latest News

🟒 HCW Biologics is trading 5.19% up today amid post-split dynamics and market strength

HCW Biologics is trading 5.19% up at $4.66 today amid post-split trading dynamics and broader market gains. β€’ The stock's 1-for-6 reverse split became...

🟒 HCWB is trading 6.3% up today as volatility persists following its 1-for-6 reverse split

HCWB is trading at $4.75 (6.3% up) in after-hours trading as investors continue to digest its recent 1-for-6 reverse split and Nasdaq bid-price compliance...

πŸ”΄ HCWB is trading 5.7% down today after 1-for-6 reverse split and Nasdaq compliance news

HCWB is trading at $4.36 (5.7% down) as traders digest its recent 1-for-6 reverse stock split and Nasdaq bid-price compliance news. β€’ The stock has...

HCW Biologics Pulls the Reverse-Split Lever, but Can a Share-Price Reset Mask Deeper Trouble?

HCW Biologics Pulls the Reverse-Split Lever, but Can a Share-Price Reset Mask Deeper Trouble?

Shares of HCW Biologics surged in pre-market trading to $4.71, up 9.5% from the prior close of $4.30, as the micro-cap immunology company continues to whipsaw...

🟒 HCWB is trading 9.5% up today after its 1-for-6 reverse stock split became effective

HCWB is trading at $4.71 (+9.53%) in pre-market after its 1-for-6 reverse stock split became effective on June 30, 2026. β€’ The move follows a period of...

πŸ”΄ HCWB is trading 5% down today following its 1-for-6 reverse stock split and Nasdaq compliance update

HCWB is trading at $4.74 (5% down) as investors digest its June 30 one-for-six reverse stock split and Nasdaq bid-price compliance update. β€’ The stock...

🟒 HCWB makes sharp 11.2% jump

HCWB is trading at $5.55, up 11.2% versus the comparison close of $4.99 during after-hours. This is a price-movement alert; no separate company-specific...

🟒 HCWB is trading 6% up today after reverse stock split and Nasdaq compliance

HCWB is trading at $5.29 (6% up) in after-hours trading after implementing a 1-for-6 reverse stock split and regaining Nasdaq bid-price compliance. β€’ The...

🟒 HCWB is trading 469.6% up today after regaining Nasdaq compliance via a 1-for-6 reverse stock split

HCWB is trading at $4.99, up 469.63% today after HCW Biologics regained Nasdaq bid-price compliance and implemented a 1-for-6 reverse stock split. β€’ The...

🟒 HCWB is trading 536.4% up today after regaining Nasdaq compliance via a 1-for-6 reverse split

HCWB is trading 536.4% up at $5.58 after implementing a 1-for-6 reverse stock split and confirming it has regained Nasdaq bid-price compliance for continued...

🟒 HCWB is trading 8.45% up today after regaining Nasdaq compliance and announcing a 1-for-6 reverse split

HCWB is trading at $5.70 (8.45% up) after HCW Biologics announced it regained Nasdaq bid-price compliance and will execute a 1-for-6 reverse stock split. β€’...

HCW Biologics Regains Nasdaq Compliance, Announces 1-for-6 Reverse Stock Split

HCW Biologics Regains Nasdaq Compliance, Announces 1-for-6 Reverse Stock Split

HCW Biologics announced it has regained compliance with the Nasdaq's minimum bid price requirement, as confirmed by the Nasdaq Hearings Panel on June 29, 2026....

🟒 HCW Biologics Inc is trading 9.58% up in after-hours

HCWB is trading at $0.96, up 9.58% in after-hours.

πŸ”΄ HCWB makes sharp 12.9% drop

HCWB is trading at $0.90, down 12.9% versus the comparison close of $1.03 during regular trading. This is a price-movement alert; no separate company-specific...

πŸ”΄ HCWB is trading 7.8% down today on a 1-for-6 reverse stock split announcement

HCWB is trading at $0.95 (7.8% down) as investors react to the company's recently announced 1-for-6 reverse stock split. β€’ The reverse split, effective June...

🟒 HCWB is trading 6.3% up today after announcing a 1-for-6 reverse stock split

HCWB is trading 6.3% up at $1.09 in pre-market after announcing a 1-for-6 reverse stock split effective June 30, 2026. β€’ The corporate action, detailed in a...

HCWB's Second Reverse Split in 14 Months: Can a Clinical-Stage Biotech Survive on Financial Engineering Alone?

HCWB's Second Reverse Split in 14 Months: Can a Clinical-Stage Biotech Survive on Financial Engineering Alone?

Shares of HCW Biologics dropped 15.2% to $0.95 after the company announced its board approved a 1-for-6 reverse stock split, effective June 30, 2026 β€” the...

πŸ”΄ HCWB is trading 15% down today after announcing a 1-for-6 reverse split for Nasdaq compliance

HCWB is trading 15% down at $0.95 after its Board approved a 1-for-6 reverse stock split aimed at maintaining compliance with Nasdaq’s $1.00 minimum bid price...

HCW Biologics Announces 1-for-6 Reverse Stock Split to Maintain Nasdaq Listing

HCW Biologics Announces 1-for-6 Reverse Stock Split to Maintain Nasdaq Listing

HCW Biologics Inc. (HCWB) announced its Board of Directors has approved a 1-for-6 reverse stock split of its common stock, effective June 30, 2026. This action...

πŸ”΄ HCWB Plunges 23.9% After Announcing 1-for-6 Reverse Stock Split

HCWB is trading at $0.85 (23.9% down) after HCW Biologics announced a 1-for-6 reverse stock split of its common stock, effective June 30, 2026. β€’ The reverse...